Literature DB >> 3260671

Infusions of recombinant human interleukins 1 alpha and 1 beta cause hypercalcemia in normal mice.

M Sabatini1, B Boyce, T Aufdemorte, L Bonewald, G R Mundy.   

Abstract

The immune cell products interleukins 1 alpha and -beta, which stimulate osteoclast activity in vitro, are among the most potent bone resorbing factors so far described. Although it appears likely that these cytokines are involved in regulation of trabecular bone turnover, nothing is known of their effects on extracellular fluid calcium concentration. In this report, we show the effects of 72-hr subcutaneous infusions of interleukins 1 alpha and -beta on plasma calcium and bone morphology in mice. Both interleukins 1 caused a marked dose-dependent increase in the plasma calcium. In higher doses, which cause the animals to die, the plasma calcium fell preterminally. Quantitative histomorphometry of bone sections showed evidence of increased numbers of osteoclasts and bone resorption surfaces. The effects were similar to those obtained with infusions of parathyroid hormone. These data suggest that in addition to its potential influence on trabecular bone volume, interleukin 1 may also modulate extracellular fluid calcium homeostasis under conditions in which it is produced excessively.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3260671      PMCID: PMC281724          DOI: 10.1073/pnas.85.14.5235

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  16 in total

1.  Characterization of the effects of endotoxin on macrophage tumor cell killing.

Authors:  J B Weinberg; H A Chapman; J B Hibbs
Journal:  J Immunol       Date:  1978-07       Impact factor: 5.422

2.  Evidence for the secretion of an osteoclast stimulating factor in myeloma.

Authors:  G R Mundy; L G Raisz; R A Cooper; G P Schechter; S E Salmon
Journal:  N Engl J Med       Date:  1974-11-14       Impact factor: 91.245

3.  Bone resorbing activity in supernatant fluid from cultured human peripheral blood leukocytes.

Authors:  J E Horton; L G Raisz; H A Simmons; J J Oppenheim; S E Mergenhagen
Journal:  Science       Date:  1972-09-01       Impact factor: 47.728

4.  Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors.

Authors:  D R Bertolini; G E Nedwin; T S Bringman; D D Smith; G R Mundy
Journal:  Nature       Date:  1986 Feb 6-12       Impact factor: 49.962

5.  Purification and partial sequence of human osteoclast-activating factor: identity with interleukin 1 beta.

Authors:  F E Dewhirst; P P Stashenko; J E Mole; T Tsurumachi
Journal:  J Immunol       Date:  1985-10       Impact factor: 5.422

6.  Enzyme-linked immunoelectrotransfer blot techniques (EITB) for studying the specificities of antigens and antibodies separated by gel electrophoresis.

Authors:  V C Tsang; J M Peralta; A R Simons
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

7.  An interleukin 1 like factor stimulates bone resorption in vitro.

Authors:  M Gowen; D D Wood; E J Ihrie; M K McGuire; R G Russell
Journal:  Nature       Date:  1983 Nov 24-30       Impact factor: 49.962

8.  Parathyroid function and magnesium depletion in the rat.

Authors:  C S Anast; L F Forte
Journal:  Endocrinology       Date:  1983-07       Impact factor: 4.736

9.  Pig interleukin 1 (catabolin) is a potent stimulator of bone resorption in vitro.

Authors:  J K Heath; J Saklatvala; M C Meikle; S J Atkinson; J J Reynolds
Journal:  Calcif Tissue Int       Date:  1985-01       Impact factor: 4.333

10.  Preferential inhibition of cytokine-stimulated bone resorption by recombinant interferon gamma.

Authors:  M Gowen; G E Nedwin; G R Mundy
Journal:  J Bone Miner Res       Date:  1986-10       Impact factor: 6.741

View more
  37 in total

Review 1.  Pathophysiological tissue changes associated with repetitive movement: a review of the evidence.

Authors:  Ann E Barr; Mary F Barbe
Journal:  Phys Ther       Date:  2002-02

2.  Genetics of the bone response to bisphosphonate treatments.

Authors:  Francesco Massart; Maria Luisa Brandi
Journal:  Clin Cases Miner Bone Metab       Date:  2009-01

3.  Is there a causal role for IL-1 in postmenopausal bone loss?

Authors:  R Pacifici
Journal:  Calcif Tissue Int       Date:  1992-04       Impact factor: 4.333

4.  Immobilization-related hypercalcaemia--a possible novel mechanism and response to pamidronate.

Authors:  S J Gallacher; S H Ralston; F J Dryburgh; F C Logue; B F Allam; B F Boyce; I T Boyle
Journal:  Postgrad Med J       Date:  1990-11       Impact factor: 2.401

Review 5.  Osteoimmunology: interactions of the bone and immune system.

Authors:  Joseph Lorenzo; Mark Horowitz; Yongwon Choi
Journal:  Endocr Rev       Date:  2008-05-01       Impact factor: 19.871

6.  Talc granulomatosis in the rat. Involvement of bone in the acute-phase response.

Authors:  A Marusić; K Kos; A Stavljenić; S Vukicević
Journal:  Inflammation       Date:  1990-04       Impact factor: 4.092

7.  Bone resorption caused by three periodontal pathogens in vivo in mice is mediated in part by prostaglandin.

Authors:  Y Zubery; C R Dunstan; B M Story; L Kesavalu; J L Ebersole; S C Holt; B F Boyce
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

8.  Interleukin-1 receptor antagonist decreases bone loss and bone resorption in ovariectomized rats.

Authors:  R B Kimble; J L Vannice; D C Bloedow; R C Thompson; W Hopfer; V T Kung; C Brownfield; R Pacifici
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

9.  Bone matrix constituents stimulate interleukin-1 release from human blood mononuclear cells.

Authors:  R Pacifici; A Carano; S A Santoro; L Rifas; J J Jeffrey; J D Malone; R McCracken; L V Avioli
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

10.  Effects of estrogen replacement on insulin-like growth factor I concentrations in serum and bone tissue and on interleukin 1 secretion from spleen macrophages in oophorectomized rats.

Authors:  F Sato; Y Ouchi; A Masuyama; T Nakamura; T Hosoi; Y Okamoto; N Sasaki; M Shiraki; H Orimo
Journal:  Calcif Tissue Int       Date:  1993-08       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.